# US 2024/0350707 A1 · Tissue scaffold and scaffold composition

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0350707 A1
- Document ID: US20240350707A1
- Status: Published application
- Kind: A1
- Application number: 18/533,459
- Filed: 2023-12-08
- Published: 2024-10-24
- Earliest claimed: 2017-02-15
- Assignees: Locate Bio Limited
- Applicants: Locate Bio Limited
- Inventors: Antonio LEONARDI; Helen Celia COX; Robin Andrew Quirk; Kevin Morris Shakesheff
- Web page: https://patentgrep.com/patent/US20240350707A1

## CPC

- A61L 27/26: Mixtures of macromolecular compounds
- A61K 38/1875: {Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor}
- A61L 27/10: Ceramics or glasses
- A61L 27/12: Phosphorus-containing materials, e.g. apatite
- A61L 27/18: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 27/38: {containing added animal cells (organs or tissue containing native cells A61L27/36)}
- A61L 27/502: {Plasticizers}
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 2300/252: Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
- A61L 2300/62: Encapsulated active agents, e.g. emulsified droplets
- A61L 2430/02: for reconstruction of bones; weight-bearing implants
- A61L 2430/12: for dental implants or prostheses
- A61L 2430/38: for reconstruction of the spine, vertebrae or intervertebral discs
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The invention relates to a scaffold material composition for forming a solid tissue scaffold, the composition comprising a plurality of hollow polymer pellets, each pellet comprising an open hollow extending through the pellet, and wherein the plurality of hollow polymer pellets are capable of interlinking and setting into a solid scaffold. The invention further relates to associated compositions, uses, method of treatment and kits associated with such material.

## Claims

### Claim at position 1

1-51. (canceled)

### Claim 52

A kit for use in forming a scaffold comprising:
(a) hollow polymer pellets, each pellet comprising an open hollow extending through the pellet,
wherein the hollow polymer pellets have a tubular structure, with the lumen extending therethrough, or wherein the hollow polymer pellets have a tubular structure and the lumen is in the form of a channel running through the pellet structure, whereby the channel is open substantially along its length, and
wherein the lumen volume is at least 10% of each hollow polymer pellet; and
(b) non-polymer particles, wherein the non-polymer particles comprise or consist of calcium phosphate, α-tricalcium phosphate, β-tricalcium phosphate, or hydroxyapatite.

### Claim 53 (depends on 52)

The kit according to claim 52, wherein the kit further comprises a carrier solution.

### Claim 54 (depends on 52)

The kit according to claim 52, wherein the scaffold comprises between 1% and 55% w/w β-TCP.

### Claim 55 (depends on 52)

The kit according to claim 52, wherein the hollow polymer pellets have an aspect ratio (length:width) of from 6:1 to 1:6.

### Claim 56 (depends on 55)

The kit according to claim 55, wherein the hollow polymer pellets have an aspect ratio (length:width) of from 4:1 to 1:4.

### Claim 57 (depends on 52)

The kit according to claim 52, wherein the non-polymer particles comprise or consist of β-tricalcium phosphate.

### Claim 58 (depends on 52)

The kit according to claim 52, wherein the hollow polymer pellets comprise one or more polymer selected from the group comprising poly (D,L-lactide-co-glycolide)(PLGA), poly D,L-lactic acid (PDLLA), polyethyleneimine (PEI), polylactic or polyglycolic acids, poly-lactide poly-glycolide copolymers, and poly-lactide, poly-glycolide, polyethylene glycol copolymers, polyethylene glycol (PEG), polyesters, poly (ε-caprolactone), poly (3-hydroxy-butyrate), poly (s-caproic acid), poly (p-dioxanone), poly (propylene fumarate), poly (ortho esters), polyol/diketene acetals addition polymers, polyanhydrides, poly (sebacic anhydride) (PSA), poly (carboxybiscarboxyphenoxyphosphazene) (PCPP), poly [bis (p-carboxyphenoxy) methane] (PCPM), copolymers of SA, CPP and CPM, poly (amino acids), poly (pseudo amino acids), polyphosphazenes, derivatives of poly [(dichloro) phosphazene], poly [(organo) phosphazenes], polyphosphates, polyethylene glycol polypropylene block co-polymers, natural or synthetic polymers, silk, elastin, chitin, chitosan, fibrin, fibrinogen, polysaccharides, peptides, polypeptides, proteins, copolymers prepared from the monomers of any of these polymers, or blends, mixtures or combinations thereof.

### Claim 59 (depends on 52)

The kit according to claim 52, wherein the kit further comprises an active agent.

### Claim 60 (depends on 59)

The kit according to claim 59, wherein the active agent is encapsulated within the hollow polymer pellets.

### Claim 61

A solid scaffold for tissue repair or replacement comprising:
a plurality of hollow polymer pellets, each pellet comprising an open hollow extending through the pellet,
wherein the hollow polymer pellets have a tubular structure, with the lumen extending therethrough, or wherein the hollow polymer pellets have a tubular structure and the lumen is in the form of a channel running through the pellet structure, whereby the channel is open substantially along its length,
wherein the lumen volume is at least 10% of each hollow polymer pellet; and
non-polymer particles, wherein the non-polymer particles comprise or consist of calcium phosphate, α-tricalcium phosphate, β-tricalcium phosphate, or hydroxyapatite.

### Claim 62 (depends on 61)

The solid scaffold according to claim 61, wherein the solid scaffold comprises between 1% and 55% w/w β-TCP.

### Claim 63 (depends on 61)

The solid scaffold according to claim 61, wherein the hollow polymer pellets have an aspect ratio (length:width) of from 6:1 to 1:6.

### Claim 64 (depends on 63)

The solid scaffold according to claim 63, wherein the hollow polymer pellets have an aspect ratio (length:width) of from 4:1 to 1:4.

### Claim 65 (depends on 61)

The solid scaffold according to claim 61, wherein the non-polymer particles comprise or consist of β-tricalcium phosphate.

### Claim 66 (depends on 61)

The solid scaffold according to claim 61, wherein the solid scaffold comprises an active agent.

### Claim 67 (depends on 66)

The solid scaffold according to claim 66, wherein the active agent is encapsulated within the hollow polymer pellets.

### Claim 68 (depends on 61)

The solid scaffold according to claim 61, wherein the hollow polymer pellets comprise one or more polymer selected from the group comprising poly (D,L-lactide-co-glycolide)(PLGA), poly D,L-lactic acid (PDLLA), polyethyleneimine (PEI), polylactic or polyglycolic acids, poly-lactide poly-glycolide copolymers, and poly-lactide, poly-glycolide, polyethylene glycol copolymers, polyethylene glycol (PEG), polyesters, poly (ε-caprolactone), poly (3-hydroxy-butyrate), poly (s-caproic acid), poly (p-dioxanone), poly (propylene fumarate), poly (ortho esters), polyol/diketene acetals addition polymers, polyanhydrides, poly (sebacic anhydride) (PSA), poly (carboxybiscarboxyphenoxyphosphazene) (PCPP), poly [bis (p-carboxyphenoxy) methane] (PCPM), copolymers of SA, CPP and CPM, poly (amino acids), poly (pseudo amino acids), polyphosphazenes, derivatives of poly [(dichloro) phosphazene], poly [(organo) phosphazenes], polyphosphates, polyethylene glycol polypropylene block co-polymers, natural or synthetic polymers, silk, elastin, chitin, chitosan, fibrin, fibrinogen, polysaccharides, peptides, polypeptides, proteins, copolymers prepared from the monomers of any of these polymers, or blends, mixtures or combinations thereof.
